论文部分内容阅读
1介入治疗中抗血小板药物应用的争议经皮冠状动脉介入治疗(PCI)术辅助抗血小板治疗能显著降低术中和术后急性及亚急性血栓形成,降低主要心脏不良事件的发生,已成为PCI术重要、常规的治疗,但仍存在以下一些未确定的问题,如阿司匹林抵抗、氯吡格雷抵抗、氯吡格雷的最佳负荷剂量、
1 interventional anti-platelet drugs in the controversial application of percutaneous coronary intervention (PCI) assisted antiplatelet therapy can significantly reduce intraoperative and postoperative acute and subacute thrombosis and reduce the incidence of major cardiac adverse events, has become PCI There are still some undetermined problems such as aspirin resistance, clopidogrel resistance, optimal loading dose of clopidogrel,